Over a 15-year follow-up study, MASLD significantly heightened the risk of cirrhosis & hepatocellular carcinoma in chronic hepatitis B (CHB) or C infections. 

- While MASLD markedly elevated the combined risks of cirrhosis or HCC, the risk was notably higher when comparing CHB or C infection with MASLD. 
- Chronic Viral Hepatitis B and C outweighed MASLD in the associated risk of cirrhosis and HCC
- Even among patients receiving antivirals, MASLD remained a significant factor in increased risks of cirrhosis and HCC.

These findings underscore the need to prioritize treatment of chronic viral hepatitis before addressing MASLD.

Source: CGH | [Read full story](https://www.cghjournal.org/article/S1542-3565(24)00198-8/abstract?rss=yes)